Relapsed Lymphomas
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas (NCT00785798) | Yale University | 2009-01-01 |
Track Relapsed Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.